Keywords: Biosimilars, Follow-on biologics, USA, FDA hearings, Legislaton, BIO, PhRMA, GPhA

Pharma industry groups and companies set out their aims for US biosimilars legislation at FDA hearing

Article | 05 November 2010

Representatives of the pharmaceutical, biotechnology and generic drugs industries spent a couple of days this week at the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in